Symbol
|
KNXHDU | Z07GPZ | Z07GQZ | XLOLTQ | MURRCH | RMASBV | RMBTIV | RMA1UV | MZBRCH | RMBIPV | YENLTQ | RMACUV | NIZRCH | RMBUPV | RMAG9V | YUILTQ | RMAQXV | NQLRCH | NTSRCH | ABGMSQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nom | Autocallable Multi Barrier Reverse Convertible | ZKB Autocallable BRC Last Look on worst of | ZKB Autocallable BRC Last Look on worst of | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible with European Knock-In | Worst of Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible |
Sous-jacent
|
Novartis Sandoz Basket / Novo Nordisk AS (B) / Roche AG / Sanofi S.A. | Novo Nordisk AS (B) / Siemens AG / Unilever N.V. / Veolia Environnement S.A. | Novo Nordisk AS (B) / Siemens AG / Unilever N.V. / Veolia Environnement S.A. | Bayer AG / Novo Nordisk AS (B) / Sanofi S.A. | Merck & Co. Inc. / Novo Nordisk AS (B) / Roche GS | Eli Lilly & Co. / Novo Nordisk AS (B) | Bayer AG / Novartis Sandoz Basket / Novo Nordisk AS (B) / Roche AG | LVMH Moet Hennessy Louis Vuitton / Nestlé S.A. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Alcon / Novartis Sandoz Basket / Novo Nordisk AS (B) / Roche AG | Alcon / Novo Nordisk AS (B) / Sanofi S.A. | Novo Nordisk AS (B) / Ypsomed Hldg. AG | Bayer AG / Novartis AG / Novo Nordisk AS (B) / Roche AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche AG | Novo Nordisk AS (B) / Pfizer Inc. / Roche AG | Lindt & Sprüngli AG PS / Novo Nordisk AS (B) / Roche AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) | Eli Lilly & Co. / Johnson & Johnson / Novo Nordisk AS (B) |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
30.09.2024 | 20.04.2026 | 20.04.2026 | 21.01.2025 | 25.02.2025 | 10.03.2025 | 29.09.2025 | 07.04.2025 | 25.03.2025 | 29.09.2025 | 16.04.2025 | 29.04.2025 | 04.06.2025 | 17.06.2025 | 22.12.2025 | 28.03.2025 | 27.01.2025 | 05.08.2025 | 26.11.2025 | 11.03.2025 |
Demande | 99,45 | 99,01 | 99,56 | 62,30 | 101,42 | 102,00 | 84,40 | 99,40 | 101,37 | 100,00 | 101,10 | 101,40 | 99,35 | 103,30 | 102,70 | 101,62 | 100,00 | 101,28 | 100,04 | 101,87 |
Offre | 100,50 | 99,71 | 100,26 | - | 102,23 | 102,80 | - | 100,20 | 102,18 | - | 101,91 | 102,20 | 100,15 | 104,10 | 103,60 | 102,44 | 100,80 | 102,14 | 100,84 | 102,69 |